128 related articles for article (PubMed ID: 8078195)
1. [Hypoplastic leukemia successfully treated by oral administration with cytarabine ocfosfate].
Okuyama Y; Kitazume K; Iwabe K; Usuki K; Urabe A
Rinsho Ketsueki; 1994 Jun; 35(6):593-7. PubMed ID: 8078195
[TBL] [Abstract][Full Text] [Related]
2. [Successful treatment of refractory anemia with excess of blasts in transformation with cytarabine ocfosfate].
Takeuchi M; Kojima K; Takaba S; Isokawa M; Tanimizu M; Kimura F; Ohmoto E; Harada M
Gan To Kagaku Ryoho; 1995 Jan; 22(1):141-4. PubMed ID: 7826071
[TBL] [Abstract][Full Text] [Related]
3. [Low-dose cytarabine ocfosfate therapy in an elderly acute myelogenous leukemia].
Hamaoka R; Jozaki K; Amano T; Itoh H; Imai Y; Nishikawa M; Kurokawa M; Yonezawa T; Chinen Y
Gan To Kagaku Ryoho; 1995 May; 22(6):819-22. PubMed ID: 7755392
[TBL] [Abstract][Full Text] [Related]
4. [Successful treatment of acute myelogenous leukemia in an elderly patient with cytarabine ocfosfate].
Inaba T; Shimazaki C; Tatsumi T; Yamagata N; Hirata T; Goto H; Fujita N; Nakagawa M; Fujita N; Miyazaki S
Gan To Kagaku Ryoho; 1994 Mar; 21(4):535-8. PubMed ID: 8129396
[TBL] [Abstract][Full Text] [Related]
5. [Complete remission by cytarabine ocfosfate plus G-CSF therapy in a patient with hypoplastic RAEB-T].
Kadowaki I; Sasaki O; Sasaki T; Ishizawa K; Kimura J; Nomura J; Furuyama K; Harigae H; Shishido T; Okuda M
Gan To Kagaku Ryoho; 1995 Jan; 22(1):145-7. PubMed ID: 7529978
[No Abstract] [Full Text] [Related]
6. [A case of complete remission from acute unclassified leukemia achieved by using a prodrug of ara C, stearyl-ara-CMP (YNK01)].
Nishikawa M; Morita K; Komada F; Uemura Y; Kageyama S; Minami N; Deguchi K; Shirakawa S
Gan No Rinsho; 1990 Oct; 36(12):2204-9. PubMed ID: 2232191
[TBL] [Abstract][Full Text] [Related]
7. [Continuation of complete remission by oral administration of cytarabine ocfosfate in a patient with M0, who achieved remission by small doses of cytosine arabinoside with G-CSF].
Aoki S; Koyama S; Goto T; Takahashi H; Shibata A
Rinsho Ketsueki; 1995 Jan; 36(1):40-4. PubMed ID: 7536275
[TBL] [Abstract][Full Text] [Related]
8. [Refractory anemia with excess myeloblast in transformation induced remission by combined oral administration of cytarabine ocfosfate and 6-mercaptopurine].
Fukumi S; Mizorogi F; Matsuo A; Sato H; Abe T
Gan To Kagaku Ryoho; 1995 Jun; 22(7):945-8. PubMed ID: 7794001
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of refractory hematologic malignancies by combination of cytarabine ocfosfate and etoposide].
Kiyama Y; Suzuki G; Masauzi N; Ohizumi H; Kobayashi N; Ogasawara M; Naohara T; Saito M; Higa T; Kasai M
Gan To Kagaku Ryoho; 1996 Oct; 23(12):1717-20. PubMed ID: 8886052
[TBL] [Abstract][Full Text] [Related]
10. [Successful treatment of acute myelomonocytic leukemia developed from MDS with cytarabine ocfosfate (SPAC)].
Wake A; Takazawa A; Serino Y; Tonai S; Nakanishi M; Murakami S; Ogawa R; Nagata K; Mori N; Nakata K
Gan To Kagaku Ryoho; 1995 Feb; 22(3):395-8. PubMed ID: 7880111
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow cytogenetic complete remission achieved by interferon-alpha plus cytarabine ocfosfate therapy in a patient with chronic myelogenous leukemia during extramedullary blast crisis.
Gotoh A; Miyazawa K; Uchida Y; Sashida G; Kawakubo K; Kuriyama Y; Ohyashiki K
Int J Hematol; 2002 Feb; 75(2):191-4. PubMed ID: 11939268
[TBL] [Abstract][Full Text] [Related]
12. [A pharmacokinetic study of the value of oral cytarabine ocfosfate in the treatment of hematological malignancies].
Ueda Y; Mori S; Ito T; Maesako Y; Konishi H; Yagiri Y
Rinsho Ketsueki; 1998 May; 39(5):348-54. PubMed ID: 9637884
[TBL] [Abstract][Full Text] [Related]
13. [Oral administration of cytarabine ocfosfate and ondansetron hydrochloride in patients with acute myeloid leukemia who can not be treated with intensive chemotherapy:--attempt to make their quality of life better].
Yano K; Matsui H; Fujisawa S
Gan To Kagaku Ryoho; 1998 Feb; 25(3):427-30. PubMed ID: 9492840
[No Abstract] [Full Text] [Related]
14. [Five cases of myelodysplastic syndrome treated with cytarabine ocfosfate].
Nishi T; Funasako M; Hata N; Andoh K; Itoh Y; Ono H; Itoh K; Sato Y; Sato H; Taniji M; Nakai S; Ueda A; Fujimoto H; Ohata M
Gan To Kagaku Ryoho; 1996 Sep; 23(10):1331-4. PubMed ID: 8831748
[TBL] [Abstract][Full Text] [Related]
15. [Effects of cytarabine ocfosfate on colony-stimulating factor in myelodysplastic syndrome with monosomy 7].
Masumoto A; Ohbayashi Y; Kawada H; Arimori K; Sasao T; Ogawa Y; Fujiwara H; Fukuda R; Watanabe S; Umeda Y
Rinsho Ketsueki; 1994 Jun; 35(6):603-8. PubMed ID: 7521405
[TBL] [Abstract][Full Text] [Related]
16. [Minimally differentiated hypoplastic leukemia].
Mitsuhashi S; Nagasawa T; Kamoshita M; Otani K; Hasegawa Y; Kojima H; Ninomiya H; Nakazawa M; Abe T
Rinsho Ketsueki; 1995 Feb; 36(2):115-20. PubMed ID: 7715082
[TBL] [Abstract][Full Text] [Related]
17. [A new antileukemic drug, cytarabine ocfosfate].
Tsukagoshi S
Gan To Kagaku Ryoho; 1993 Sep; 20(12):1877-83. PubMed ID: 8379682
[TBL] [Abstract][Full Text] [Related]
18. [Hypoplastic leukemia which achieved remission with administration of M-CSF along with low dose ara-C].
Kamimura N; Nakamura T
Rinsho Ketsueki; 1993 May; 34(5):662-6. PubMed ID: 8315838
[TBL] [Abstract][Full Text] [Related]
19. [A 45-year-old man with peripheral monocytosis and right hemiparesis].
Takubo H; Hattori N; Irie S; Mizutani Y; Mori H; Suda K; Kondo T; Oshimi K; Mizuno Y
No To Shinkei; 1998 May; 50(5):481-9. PubMed ID: 9621375
[TBL] [Abstract][Full Text] [Related]
20. [A combination chemotherapy with cytarabine ocfosfate, low dose etoposide, and G-CSF for the treatment of high risk MDS (RAEB, RAEBt)--a pilot study].
Hara M; Kojima K; Azuma T; Narumi H; Shinagawa K
Rinsho Ketsueki; 1998 Apr; 39(4):314-6. PubMed ID: 9597900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
